172 related articles for article (PubMed ID: 15024394)
1. Antipsychotic drugs antagonize human serotonin type 3 receptor currents in a noncompetitive manner.
Rammes G; Eisensamer B; Ferrari U; Shapa M; Gimpl G; Gilling K; Parsons C; Riering K; Hapfelmeier G; Bondy B; Zieglgänsberger W; Holsboer F; Rupprecht R
Mol Psychiatry; 2004 Sep; 9(9):846-58, 818. PubMed ID: 15024394
[TBL] [Abstract][Full Text] [Related]
2. Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor.
Eisensamer B; Rammes G; Gimpl G; Shapa M; Ferrari U; Hapfelmeier G; Bondy B; Parsons C; Gilling K; Zieglgänsberger W; Holsboer F; Rupprecht R
Mol Psychiatry; 2003 Nov; 8(12):994-1007. PubMed ID: 14647397
[TBL] [Abstract][Full Text] [Related]
3. Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors.
Oz M; Zhang L; Rotondo A; Sun H; Morales M
Synapse; 2003 Dec; 50(4):303-13. PubMed ID: 14556235
[TBL] [Abstract][Full Text] [Related]
4. General anesthetic-induced channel gating enhancement of 5-hydroxytryptamine type 3 receptors depends on receptor subunit composition.
Solt K; Stevens RJ; Davies PA; Raines DE
J Pharmacol Exp Ther; 2005 Nov; 315(2):771-6. PubMed ID: 16081679
[TBL] [Abstract][Full Text] [Related]
5. Functional antagonistic properties of clozapine at the 5-HT3 receptor.
Hermann B; Wetzel CH; Pestel E; Zieglgänsberger W; Holsboer F; Rupprecht R
Biochem Biophys Res Commun; 1996 Aug; 225(3):957-60. PubMed ID: 8780717
[TBL] [Abstract][Full Text] [Related]
6. Serotonin induces the increase in intracellular Ca2+ that enhances neurite outgrowth in PC12 cells via activation of 5-HT3 receptors and voltage-gated calcium channels.
Homma K; Kitamura Y; Ogawa H; Oka K
J Neurosci Res; 2006 Aug; 84(2):316-25. PubMed ID: 16688720
[TBL] [Abstract][Full Text] [Related]
7. Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis.
Kuroki T; Nagao N; Nakahara T
Prog Brain Res; 2008; 172():199-212. PubMed ID: 18772034
[TBL] [Abstract][Full Text] [Related]
8. Molecular actions of propofol on human 5-HT3A receptors: enhancement as well as inhibition by closely related phenol derivatives.
Barann M; Linden I; Witten S; Urban BW
Anesth Analg; 2008 Mar; 106(3):846-57, table of contents. PubMed ID: 18292429
[TBL] [Abstract][Full Text] [Related]
9. Role of aspartate 298 in mouse 5-HT3A receptor gating and modulation by extracellular Ca2+.
Hu XQ; Lovinger DM
J Physiol; 2005 Oct; 568(Pt 2):381-96. PubMed ID: 16096341
[TBL] [Abstract][Full Text] [Related]
10. The effects of morphine on human 5-HT3A receptors.
Wittmann M; Peters I; Schaaf T; Wartenberg HC; Wirz S; Nadstawek J; Urban BW; Barann M
Anesth Analg; 2006 Sep; 103(3):747-52. PubMed ID: 16931691
[TBL] [Abstract][Full Text] [Related]
11. The effects of fentanyl-like opioids and hydromorphone on human 5-HT3A receptors.
Wittmann M; Schaaf T; Peters I; Wirz S; Urban BW; Barann M
Anesth Analg; 2008 Jul; 107(1):107-12. PubMed ID: 18635474
[TBL] [Abstract][Full Text] [Related]
12. In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems.
Meltzer HY; Huang M
Prog Brain Res; 2008; 172():177-97. PubMed ID: 18772033
[TBL] [Abstract][Full Text] [Related]
13. Inward currents in neurons from newborn guinea pig intestine: mediation by 5-hydroxytryptamine type 3 receptors.
Zhai J; Gershon MD; Walsh JH; Wong HC; Kirchgessner AL
J Pharmacol Exp Ther; 1999 Oct; 291(1):374-82. PubMed ID: 10490927
[TBL] [Abstract][Full Text] [Related]
14. Modulation of ligand-gated ion channels as a novel pharmacological principle.
Nothdurfter C; Tanasic S; Rammes G; Rupprecht R
Pharmacopsychiatry; 2011 May; 44 Suppl 1():S27-34. PubMed ID: 21544743
[TBL] [Abstract][Full Text] [Related]
15. Opposite effects of presynaptic 5-HT3 receptor activation on spontaneous and action potential-evoked GABA release at hippocampal synapses.
Dorostkar MM; Boehm S
J Neurochem; 2007 Jan; 100(2):395-405. PubMed ID: 17064350
[TBL] [Abstract][Full Text] [Related]
16. Interactions of metoclopramide and ergotamine with human 5-HT(3A) receptors and human 5-HT reuptake carriers.
Walkembach J; Brüss M; Urban BW; Barann M
Br J Pharmacol; 2005 Oct; 146(4):543-52. PubMed ID: 16041395
[TBL] [Abstract][Full Text] [Related]
17. Long-term effects of JL 13, a potential atypical antipsychotic, on rat dopamine and serotonin receptor subtypes.
Moran-Gates T; Massari C; Graulich A; Liégeois JF; Tarazi FI
J Neurosci Res; 2006 Aug; 84(3):675-82. PubMed ID: 16810690
[TBL] [Abstract][Full Text] [Related]
18. Molecular cloning and pharmacological characterization of serotonin 5-HT(3A) receptor subtype in dog.
Jensen TN; Nielsen J; Frederiksen K; Ebert B
Eur J Pharmacol; 2006 May; 538(1-3):23-31. PubMed ID: 16647053
[TBL] [Abstract][Full Text] [Related]
19. Antidepressants and antipsychotic drugs colocalize with 5-HT3 receptors in raft-like domains.
Eisensamer B; Uhr M; Meyr S; Gimpl G; Deiml T; Rammes G; Lambert JJ; Zieglgänsberger W; Holsboer F; Rupprecht R
J Neurosci; 2005 Nov; 25(44):10198-206. PubMed ID: 16267227
[TBL] [Abstract][Full Text] [Related]
20. Affinity of cyamemazine metabolites for serotonin, histamine and dopamine receptor subtypes.
Benyamina A; Arbus C; Nuss P; Garay RP; Neliat G; Hameg A
Eur J Pharmacol; 2008 Jan; 578(2-3):142-7. PubMed ID: 17936750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
